Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA

被引:1
|
作者
Anouti, Ahmad [1 ]
Patel, Madhukar S. [2 ]
Vanwagner, Lisa B. [1 ]
Lee, William M. [1 ]
Asrani, Sumeet K. [3 ]
Mufti, Arjmand R. [1 ]
Rich, Nicole E. [1 ]
Vagefi, Parsia A. [2 ]
Shah, Jigesh A. [2 ]
Kerr, Thomas A. [1 ]
Pedersen, Mark [1 ]
Hanish, Steven [2 ]
Singal, Amit G. [1 ]
Cotter, Thomas G. [1 ,4 ]
机构
[1] UT Southwestern Med Ctr, Div Digest & Liver Dis, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] UT Southwestern Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
DISEASE SCORE; ADULT; AGE; IMPACT; LOBE; MODEL; RECIPIENTS; SAFETY; GRAFT;
D O I
10.1097/LVT.0000000000000228
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recent deceased-donor allocation changes in the United States may have increased high-Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); however, outcomes in these patients remain poorly defined. We aimed to examine the impact of the MELD score on LDLT outcomes. Using UNOS data (January 1, 2010-December 31, 2021), LDLT recipients were identified and stratified into low-MELD (<15), intermediate-MELD (15-24), and high-MELD (=25) groups. We compared outcomes between MELD-stratified LDLT groups and between MELD-stratified LDLT and donation after brain death liver transplantation recipients. We used Kaplan-Meier analysis to compare graft survival rates and multivariable Cox proportional hazards modeling to identify factors associated with graft outcomes. Of 3558 LDLTs, 1605 (45.1%) were low-MELD, 1616 (45.4%) intermediate-MELD, and 337 (9.5%) high-MELD. Over the study period, the annual number of LDLTs increased from 282 to 569, and the proportion of high-MELD LDLTs increased from 3.9% to 7.7%. Graft survival was significantly higher in low-MELD versus high-MELD LDLT recipients (adjusted HR = 1.36, 95% CI: 1.03-1.79); however, 5-year survival exceeded 70.0% in both groups. We observed no significant difference in graft survival between high-MELD LDLT and high-MELD donation after brain death liver transplantation recipients (adjusted HR: 1.25, 95% CI:0.99-1.58), with a 5-year survival of 71.5% and 77.3%, respectively. Low LDLT center volume (<3 LDLTs/year) and recipient life support requirement were both associated with inferior graft outcomes among high-MELD LDLT recipients. While higher MELD scores confer graft failure risk in LDLT, high-MELD LDLT outcomes are acceptable with similar outcomes to MELD-stratified donation after brain death liver transplantation recipients. Future practice guidance should consider the expansion of LDLT recommendations to high-MELD recipients in centers with expertise to help reduce donor shortage.
引用
收藏
页码:72 / 82
页数:11
相关论文
共 50 条
  • [1] LIVING DONOR LIVER TRANSPLANTATION FOR HIGH-MELD PATIENTS: IS IT JUSTIFIED?
    Soejima, Yuji
    Yoshizumi, Tomoharu
    Ikegami, Toru
    Harada, Noboru
    Ito, Shinji
    Takeishi, Kazuki
    Nagao, Yoshihiro
    Mano, Yohei
    Yoshiya, Syohei
    Kurihara, Takeshi
    Mori, Masaki
    TRANSPLANT INTERNATIONAL, 2019, 32 : 29 - 29
  • [2] Long term outcomes of liver transplantation in a high-MELD cohort
    Lee, Jason
    Lee, Maximilian
    Shapiro, Lynn
    Yang, Alice L.
    Lapasaran, Alex S.
    Parvez, Sanah
    Komal, Ahmad
    Keeffe, Emmet B.
    Esquivel, Carlos O.
    Ahmed, Aijaz
    HEPATOLOGY, 2007, 46 (04) : 506A - 507A
  • [3] Liver Transplantation in the High-MELD Adult Patient: Is Donor Matching Fundamental?
    Pulitano, Carlo
    Joseph, David
    Verran, Deborah
    Francis, Katrine E.
    Musa, Khairil
    Strasser, Simone
    Shackel, Nicholas
    McCaughan, Geoffrey
    Crawford, Michael
    Sandroussi, Charbel
    LIVER TRANSPLANTATION, 2013, 19 : S233 - S233
  • [4] Outcomes of liver transplantation in High-MELD patients. Does MELD accurately predict survival?
    Sierra, L. Aceituno
    Magyar, C. T. J.
    Li, Z.
    Claasen, M. P.
    Ivanics, T.
    Winter, E.
    Bucur, R.
    Rukavina, N.
    Cho, W. J.
    Selzner, N.
    Bhat, M.
    Lilly, L.
    Tsien, C.
    Patel, K.
    Selzner, M.
    McGilvray, I.
    Reichman, T.
    Shwaartz, C.
    Ghanekar, A.
    Cattral, M.
    Sayed, B.
    Jaeckel, E.
    Sapisochin, G.
    LIVER TRANSPLANTATION, 2024, 30 : 145 - 146
  • [5] Determinants of Optimal Outcomes in High Meld Living Donor Liver Transplantation: A North American Experience
    Anouti, A.
    Patel, M. S.
    Hanish, S.
    Vagefi, P. A.
    Shah, J.
    VanWagner, L. B.
    Lee, W. M.
    Mufti, A.
    Pedersen, M. R.
    Cotter, T. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S862 - S862
  • [6] Living Donor Liver Transplantation for High MELD Score Patients.
    Chou, H.
    Lee, C.
    Soong, R.
    Wu, T.
    Wu, T.
    Chan, K.
    Lee, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 509 - 509
  • [7] Living donor liver transplantation in the USA
    Kim, Peter T. W.
    Testa, Giuliano
    HEPATOBILIARY SURGERY AND NUTRITION, 2016, 5 (02) : 133 - 140
  • [8] Is There A Role For MELD In Adult Living Donor Liver Transplantation?
    Dayangac, Murat
    Akyildiz, Murat
    Guler, Necdet
    Oklu, Levent
    Yuzer, Yildiray
    Tokat, Yaman
    HEPATOLOGY, 2013, 58 : 782A - 782A
  • [9] How to Select Elderly Patients for Living Donor Liver Transplantation With Acceptable Outcomes
    Furukawa, Kenei
    Haruki, Koichiro
    Taniai, Tomohiko
    Kawai, Hironari
    Ikegami, Toru
    LIVER TRANSPLANTATION, 2021, 27 (10) : 1502 - 1503
  • [10] Experience of Living Donor Liver Transplantation for High MELD Score Recipients.
    Ding, Chao Feng
    Wu, Jian
    Wang, Wei Lin
    Zhang, Min
    Yan, Sheng
    Tu, Zhen Hua
    Wang, Zhuo Yi
    Zheng, Shusen
    LIVER TRANSPLANTATION, 2012, 18 : S150 - S150